A clinical trial to study the effect of Siddha Medicine Hingu Chooranam for Vaayu Gunmam (Gastritis)

Phase II Non-Randomized Open Clinical Evaluation of Siddha Medicine Hingu Chooranam for Vaayu Gunmam (Gastritis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027621

Enrollment

Registered

2020-09-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K297- Gastritis, unspecified

Interventions

Intervention1: Hingu Chooranam: 1 gram of Hingu Chooranam is administered with luke warm water twice a day for 30 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Indigestion Nausea Vomiting Abdominal bloating Abdominal pain

Exclusion criteria

Exclusion criteria: Gastric perforation Appendicitis Pancreatitis Cholelithiasis CA of stomach Pregnancy&lactation Renal colic Pyloric stenosis

Design outcomes

Primary

Measure	Time frame
It is mainly assessed by reduction in the clinical symptoms of abdominal pain, abdominal bloating, indigestion, nausea and vomiting.Timepoint: 30 days	—

Secondary

Measure	Time frame
It is assessed by comparing the the clinical symptoms before and after treatment.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Shakeena Parveen A

Government Siddha Medical College

ujjeevanam@gmail.com9884175653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026